Camlin Fine Sciences Balance Sheet Health
Financial Health criteria checks 3/6
Camlin Fine Sciences has a total shareholder equity of ₹6.7B and total debt of ₹7.4B, which brings its debt-to-equity ratio to 111.2%. Its total assets and total liabilities are ₹18.9B and ₹12.2B respectively. Camlin Fine Sciences's EBIT is ₹273.8M making its interest coverage ratio 0.4. It has cash and short-term investments of ₹905.9M.
Key information
111.2%
Debt to equity ratio
₹7.39b
Debt
| Interest coverage ratio | 0.4x |
| Cash | ₹905.90m |
| Equity | ₹6.65b |
| Total liabilities | ₹12.20b |
| Total assets | ₹18.85b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 532834's short term assets (₹10.2B) exceed its short term liabilities (₹8.5B).
Long Term Liabilities: 532834's short term assets (₹10.2B) exceed its long term liabilities (₹3.7B).
Debt to Equity History and Analysis
Debt Level: 532834's net debt to equity ratio (97.5%) is considered high.
Reducing Debt: 532834's debt to equity ratio has increased from 102.4% to 111.2% over the past 5 years.
Debt Coverage: 532834's debt is well covered by operating cash flow (21.8%).
Interest Coverage: 532834's interest payments on its debt are not well covered by EBIT (0.4x coverage).